latest

# What Does Syngene International Limited’s (NSE:SYNGENE) P/E Ratio Tell You?

Want to participate in a short research study? Help shape the future of investing tools and you could win a \$250 gift card!

The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). We’ll show how you can use Syngene International Limited’s (NSE:SYNGENE) P/E ratio to inform your assessment of the investment opportunity. Syngene International has a P/E ratio of 37.77, based on the last twelve months. That is equivalent to an earnings yield of about 2.6%.

### How Do You Calculate Syngene International’s P/E Ratio?

The formula for P/E is:

Price to Earnings Ratio = Share Price ÷ Earnings per Share (EPS)

Or for Syngene International:

P/E of 37.77 = ₹601.6 ÷ ₹15.93 (Based on the year to December 2018.)

### Is A High Price-to-Earnings Ratio Good?

A higher P/E ratio implies that investors pay a higher price for the earning power of the business. That isn’t necessarily good or bad, but a high P/E implies relatively high expectations of what a company can achieve in the future.

### How Growth Rates Impact P/E Ratios

Probably the most important factor in determining what P/E a company trades on is the earnings growth. When earnings grow, the ‘E’ increases, over time. Therefore, even if you pay a high multiple of earnings now, that multiple will become lower in the future. Then, a lower P/E should attract more buyers, pushing the share price up.

Syngene International increased earnings per share by 4.8% last year. And it has bolstered its earnings per share by 15% per year over the last five years.

### How Does Syngene International’s P/E Ratio Compare To Its Peers?

The P/E ratio indicates whether the market has higher or lower expectations of a company. The image below shows that Syngene International has a higher P/E than the average (22.3) P/E for companies in the life sciences industry.

That means that the market expects Syngene International will outperform other companies in its industry. Shareholders are clearly optimistic, but the future is always uncertain. So investors should delve deeper. I like to check if company insiders have been buying or selling.

### A Limitation: P/E Ratios Ignore Debt and Cash In The Bank

Don’t forget that the P/E ratio considers market capitalization. That means it doesn’t take debt or cash into account. Theoretically, a business can improve its earnings (and produce a lower P/E in the future), by taking on debt (or spending its remaining cash).

Spending on growth might be good or bad a few years later, but the point is that the P/E ratio does not account for the option (or lack thereof).

### How Does Syngene International’s Debt Impact Its P/E Ratio?

Syngene International has net cash of ₹169m. That should lead to a higher P/E than if it did have debt, because its strong balance sheets gives it more options.

### The Bottom Line On Syngene International’s P/E Ratio

Syngene International trades on a P/E ratio of 37.8, which is above the IN market average of 16. EPS was up modestly better over the last twelve months. Also positive, the relatively strong balance sheet will allow for investment in growth — and the P/E indicates shareholders that will happen!

Investors should be looking to buy stocks that the market is wrong about. If the reality for a company is better than it expects, you can make money by buying and holding for the long term. So this free visualization of the analyst consensus on future earnings could help you make the right decision about whether to buy, sell, or hold.

You might be able to find a better buy than Syngene International. If you want a selection of possible winners, check out this free list of interesting companies that trade on a P/E below 20 (but have proven they can grow earnings).

To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at editorial-team@simplywallst.com.